Testing Needle Sizes for Prostate Biopsy in Men Suspected of Cancer
Tests different biopsy needle sizes in adults with suspected prostate cancer.
Plain-language title generated from the registry record
Registry title: Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Key facts
- Where
- Padua, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who may have prostate cancer and who have a suspicious spot on a prostate MRI scan. It compares needle sizes used for prostate biopsy.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Suspected prostate cancer, with at least one suspicious prostate lesion on MRI (PI-RADS 3 or higher, scored before the biopsy)
- Earlier treatment
- People who had radiotherapy to the prostate for cancer cannot join
- Biomarker or test result
- Raised prostate-specific antigen (PSA) and/or a suspicious digital rectal examination
Main reasons for not taking part
- Under active surveillance for prostate cancer
- Previous diagnosis of prostate cancer before the biopsy
- Previous radiotherapy to the prostate for cancer
Read by machine on 12 November 2026.
Where in Italy
- Urology Unit - Padua University HospitalPadua, ItalyContact: Fabio Zattoni, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital Padova
- Trial code
- NCT06420115
- Record updated
- 25 March 2025
- Original description
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancerRead full original descriptionShow less
AOP2780 - Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
Inclusion: Clinical suspicion of prostate cancer (presence of elevated prostatic specific antigen and/or suspicious digital rectal examination); Presence of at least one suspicious prostate lesion on MRI (Prostate Imaging-Reporting and Data System ≥ 3) according to the Prostate Imaging-Reporting and Data System v2.1 performed before Magnetic Resonance Imaging/transrectal ultrasound fusion biopsy.
Exclusion: Patients under active surveillance or with a previous diagnosis of prostate neoplasia prior to biopsy; Previous radiotherapy to the prostate for neoplasia.